← SynDRA
NAFCILLIN
SynDRA canonical compound SYN0006809 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | SLC22A6 |
| Mechanism of action | Bacterial cell wall synthesis inhibitor |
| Indication | gram-positive bacterial infections |
| Disease area | infectious disease |
All known targets
- CYP1A2
- CYP3A4
- SLC22A6
- PBP2
- mecA
- pbp4
- pbpA
- pbpF
Mechanisms of action (all sources)
- Bacterial cell wall synthesis inhibitor
- pbp4 INHIBITOR
- mecA INHIBITOR
- pbpA INHIBITOR
- PBP2 INHIBITOR
- pbpF INHIBITOR
Drug classes
- Penicillin-class Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01C · BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Cross-references
Synonyms
- naphthamidopenicillin
- nafcilin
- nallpen
- naphcillin
- nafcillin sodium
- nafcillin sodium salt monohydrate
- nafcillin sodium salt
- Nafcilline
- Nafcilina
- Nafcillinum
- Nallpen
- Naphcillin
- Naphthamidopenicillin
- Unipen
- NAFCILLIN SODIUM
- Nafcillin sodium for injection
- Nallpen In Plastic Container
- Nafcilin-1
- Nafcilina [INN-Spanish]
- Nafcillin & VRC3375
- Nafcillin (INN)
- Nafcillin [INN:BAN]
- Nafcilline [INN-French]
- Nafcillinum [INN-Latin]
- Nafcillin, Monosodium Salt, Anhydrous
- (2-Ethoxy-1-naphthyl)penicillin
- (2-ethoxy-1-naphthalenyl)penicillin
- (2S,5R,6R)-6-({[2-(ethyloxy)naphthalen-1-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 6-(2-ethoxy-1-naphthamido)penicillanic acid
- 6-[(2-Ethoxy-naphthalene-1-carbonyl)-amino]-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion
- 6beta-(2-ethoxynaphthalene-1-carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
- Nafcillin sodium salt
- CHEBI:7447
- Penicillin, (2-ethoxy-1-naphthalenyl)-
- 4CNZ27M7RV
- NAFCILLIN [INN]
Reported adverse events
- Agranulocytosis
- Nausea
- Pseudomembranous colitis
Look up NAFCILLIN in the interactive SynDRA portal →